Interferon γ and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection

被引:38
|
作者
Zaitseva, M [1 ]
Lee, S [1 ]
Lapham, C [1 ]
Taffs, R [1 ]
King, L [1 ]
Romantseva, T [1 ]
Manischewitz, J [1 ]
Golding, H [1 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V96.9.3109.h8003109_3109_3117
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of interferon gamma (IFN-gamma) and interleukin 6 (IL-6) on infection of macrophages with human immunodeficiency virus type 1 (HIV-1) was investigated. By using a polymerase chain reaction-based viral entry assay and viral infectivity assay, it was demonstrated that IL-6 and IFN-gamma augmented susceptibility of monocyte-derived macrophages (MDMs) to infection with T-cell tropic CXCR4-utilizing (X4) HIV-I strains. Consistent with this finding, IFN-gamma and IL-6 augmented fusion of MDMs with T-tropic envelope-expressing cells. The enhanced fusion of cytokine-treated MDMs with T-tropic envelopes was inhibited by the CXCR4 ligand, SDF-1, and by T22 peptide. IFN-gamma and IL-6 did not affect expression of surface CXCR4 or SDF-1-induced Ca++ flux in MDMs, In contrast to the effect of IFN-gamma on the infection of MDMs with X4 strains, IFN-gamma inhibited viral entry and productive infection of MDMs with macrophage-tropic (M-tropic) HIV-1, Consistent with this finding, IFN-gamma induced a decrease in fusion with M-tropic envelopes that correlated with a modest reduction in surface CCR5 and CD4 on MDMs, It was further demonstrated that macrophage inflammatory protein (MIP)-1 alpha and MIP-beta secreted by cytokine-treated MDMs augmented their fusion with T-tropic-expressing cells and inhibited their fusion with M-tropic envelope-expressing cells. These data indicate that proinflammatory cytokines, which are produced during opportunistic infections or sexually transmitted diseases, may predispose macrophages to infection with X4 strains that, in turn, could accelerate disease progression. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:3109 / 3117
页数:9
相关论文
共 50 条
  • [41] Host and virus strain dependence in activation of human macrophages by human immunodeficiency virus type 1
    Kazmierczak, Katarzyna
    Potash, Mary Jane
    JOURNAL OF NEUROVIROLOGY, 2007, 13 (05) : 452 - 461
  • [42] Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection
    Ida, S
    Tachikawa, N
    Nakajima, A
    Daikoku, M
    Yano, M
    Kikuchi, Y
    Yasuoka, A
    Kimura, S
    Oka, S
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (03) : 379 - 385
  • [43] Human SMOOTHENED inhibits human immunodeficiency virus type 1 infection
    Yoshida, Takeshi
    Hamano, Akiko
    Ueda, Asuka
    Takeuchi, Hiroaki
    Yamaoka, Shoji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 132 - 138
  • [44] Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2
    Ylisastigui, L
    Amzazi, S
    Bakri, Y
    Vizzavona, J
    Vita, C
    Gluckman, JC
    Benjouad, A
    BIOMEDICINE & PHARMACOTHERAPY, 1998, 52 (10) : 447 - 453
  • [45] Phagocytic activity in human immunodeficiency virus type 1 infection
    Pugliese, A
    Vidotto, V
    Beltramo, T
    Torre, D
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2005, 12 (08) : 889 - 895
  • [46] Molecular monitoring of human immunodeficiency virus type 1 infection
    Clementi, M
    Bagnarelli, P
    Menzo, S
    Cardelli, M
    Mazzola, F
    Sampaolesi, R
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1997, 11 (1-2): : 64 - 68
  • [47] Neuromuscular complications of the human immunodeficiency virus type 1 infection
    Wulff, EA
    Simpson, DM
    SEMINARS IN NEUROLOGY, 1999, 19 (02) : 157 - 164
  • [48] The effects of immunization in human immunodeficiency virus type 1 infection
    Kroon, FP
    vanFurth, R
    Bruisten, SM
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (11): : 817 - 818
  • [49] Hemophilia and nonprogressing human immunodeficiency virus type 1 infection
    Vicenzi, E
    Bagnarelli, P
    Santagostino, E
    Ghezzi, S
    Alfano, M
    Sinnone, MS
    Fabio, G
    Turchetto, L
    Moretti, G
    Lazzarin, A
    Mantovani, A
    Mannucci, PM
    Clementi, M
    Gringeri, A
    Poli, G
    BLOOD, 1997, 89 (01) : 191 - 200
  • [50] Primary human immunodeficiency virus type 1 infection in pregnancy
    Keerasuntonpong, A
    Pitt, J
    Gaut, PL
    Daar, ES
    OBSTETRICS AND GYNECOLOGY, 1999, 94 (05): : 844 - 844